Loading data for BHC.TO — first visit, this takes a few seconds.

Bausch Health Companies I...

Toronto: BHC.TO · Real-Time Price · USD
8.82
-0.59 (-6.27%)
At close: Aug 24, 2026, 8:00 PM

The price, the headline numbers and the latest news, in one place.

Bausch Health Companies Inc. (BHC.TO) Stock Price, Analysis & Data

-6.27%

No data available

Bid8.78
Market Cap3.45B
Revenue (ttm)10.85B
Net Income (ttm)-1.1B
0.38
-4.06
n/a
1.6
P/B (ttm)-1.41
P/S (ttm)0.32
Earnings DateOct 28, 2026
Ask9.3
Volume2,484,254
Avg. Volume (20D)657,703
Open9.42
Previous Close9.41
Day's Range8.77 - 9.45
52-Week Range6.10 - 11.08
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend DateNov 10, 2010

About BHC.TO

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter prod...

Sector Healthcare
IPO Date Apr 3, 1996
Employees 20,300
Stock Exchange Toronto
Ticker Symbol BHC.TO
Full Company Profile

Financial Performance

In 2025, Bausch Health Companies's revenue was 10.27B, an increase of 6.66% compared to the previous year's 9.63B. Earnings were 157M, a decrease of -441.3%.

Financial numbers in CAD Financial Statements

Earnings Surprise

Bausch Health Companies has released their quarterly earnings on Jul 29, 2026:
  • Revenue of $2.85B misses estimates by $0, with 12.73% YoY growth.
  • EPS of 1.26 exceeds estimates by 0.25, with 38.46% YoY growth.
Bausch Health Companies Inc. is scheduled to release its earnings on Oct 28, 2026, after market closes.
Analysts project revenue of ... Upgrade